Leukocyte antigen CD37 activators are chemical entities that interact with and increase the activity of the CD37 protein, a member of the tetraspanin superfamily predominantly expressed on the surface of B cells and to some extent on T cells and other leukocytes. Activators in this class can directly influence the function of CD37, which is involved in various cellular processes, including cell signaling, adhesion, and the regulation of cell growth and survival. These activators can modulate the activity of CD37 by inducing conformational changes or by enhancing its interaction with other molecular partners within the membrane. They can be designed to target specific extracellular loops or intracellular domains of CD37 to elicit a desired increase in activity. For example, small molecules or biologics that bind to the extracellular regions of CD37 can trigger clustering of CD37 molecules, which can subsequently influence cellular signaling pathways.
Moreover, the activators of CD37 can also operate by stabilizing the protein within the cell membrane or by facilitating interactions with other important signaling proteins, thereby promoting signal transduction processes that CD37 is known to be involved with. Some activators can engage with the cytoplasmic tails of CD37, affecting the internal signaling cascades and the overall behavior of the cell. The activation of CD37 can lead to alterations in cellular functions such as cell-to-cell communication and the modulation of immune responses. Additionally, these activators can affect the distribution and density of CD37 on the cell surface, which can have an impact on cell adhesion properties and the formation of immunological synapses. Through these varied mechanisms, activators of CD37 can influence the activities of leukocytes and the complex interplay between different cell types within the immune system.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that can raise intracellular calcium levels, potentially modulating the signaling pathways that CD37 is involved in. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol Hydrochloride is a non-selective beta-adrenergic receptor agonist that could indirectly influence immune cell functions, potentially affecting CD37's role in cell signaling. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
PGE2 is an immunomodulatory molecule that may affect B cell function and could indirectly modulate CD37 activity. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
A phosphodiesterase inhibitor that raises cAMP levels, potentially affecting signaling pathways in B cells expressing CD37. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
An inhibitor of protein transport that could affect the trafficking of CD37 and modulate its cell surface expression. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
An activator of adenylyl cyclase which increases intracellular cAMP and may influence signaling pathways associated with CD37. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which can modulate various signaling pathways, possibly affecting the function of CD37. | ||||||